-
Tivozanib (AV-951): Redefining VEGFR Inhibition Metrics in R
2026-05-09
Explore how Tivozanib (AV-951) enables a new paradigm in renal cell carcinoma research by bridging advanced VEGFR inhibition with modern in vitro assay evaluation. This article offers a uniquely integrative perspective, addressing scientific rigor and practical protocols for oncology investigators.
-
Sunitinib Sensitization in RCC: Ferroptosis and Combination
2026-05-08
Explore how Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, achieves enhanced efficacy in renal cell carcinoma through apoptosis, cell cycle arrest, and ferroptosis induction. Uncover the latest mechanistic insights and practical applications for research workflows—distinct from standard oncology content.
-
S Tag Peptide (A6007): Technical Guide for Protein Workflows
2026-05-08
S Tag Peptide addresses key challenges in recombinant protein workflows, notably by improving protein solubility and enabling reliable detection and purification using anti-S-Tag antibodies. It is best suited for molecular biology labs seeking a practical, well-characterized fusion tag but is not recommended where ethanol solubility or prolonged solution storage is required.
-
UBE2F-SAG-Mediated RHEB Neddylation Drives mTORC1 in Liver C
2026-05-07
This study reveals that RHEB is neddylated by the UBE2F-SAG axis, enhancing mTORC1 signaling and promoting liver tumorigenesis. The findings elucidate a novel regulatory mechanism linking neddylation to mTORC1 activity and point to new therapeutic targets in hepatocellular carcinoma.
-
Go 6983: Pan-PKC Inhibitor Workflows for Cell Fate Research
2026-05-07
Go 6983 (pan-PKC inhibitor) empowers researchers to dissect PKC signaling in cancer progression, EMT, and early embryonic cell fate decisions. This guide delivers actionable protocols, troubleshooting strategies, and cross-study insights—bridging advanced mechanistic findings to bench-side applications.
-
UBE2F-SAG–Mediated RHEB Neddylation Drives mTORC1 and Liver
2026-05-06
This study uncovers RHEB as a neddylation substrate of the UBE2F-SAG axis, demonstrating that neddylation at K169 boosts mTORC1 activity and exacerbates liver tumorigenesis. The findings highlight a mechanistic link between post-translational modification, metabolic signaling, and hepatocellular carcinoma, offering a new avenue for targeted intervention.
-
CTDNEP1-NEP1R1 Regulation in ER Lipid Synthesis and Storage
2026-05-06
This study reveals that the stability and function of the phosphatase CTDNEP1 in ER membrane synthesis are critically dependent on its regulatory subunit NEP1R1, but that CTDNEP1 can control lipid droplet biogenesis independently of NEP1R1. These findings clarify the distinct mechanisms by which the ER balances lipid synthesis and storage, offering new insight into lipid homeostasis.
-
Purifying Human Mediator Complex via FLAG-Tagged CDK8 in 293
2026-05-05
Tang et al. present an efficient protocol for isolating the intact human Mediator complex—free of RNA polymerase II—by expressing FLAG-tagged CDK8 in FreeStyle 293-F cells. This workflow enables scalable, high-purity isolation suitable for structural and functional studies, streamlining research into Mediator biology and kinase module functions.
-
Temozolomide: Small-Molecule Alkylating Agent in Glioma Mode
2026-05-05
Temozolomide, a benchmark small-molecule alkylating agent, enables precision DNA damage induction and modeling of chemotherapy resistance, especially in glioma research. This article translates recent mechanistic insights and workflow optimizations into actionable guidance for advanced cancer model studies.
-
3X (DYKDDDDK) Peptide: Precision Tagging for Affinity Purifi
2026-05-04
The 3X (DYKDDDDK) Peptide enables high-sensitivity detection and robust affinity purification of recombinant proteins, outperforming traditional tags in challenging workflows like metal-dependent ELISA and protein crystallization. This guide translates latest research and expert troubleshooting into actionable strategies for maximizing reproducibility and yield in protein science.
-
Plk1 Regulation of p31comet Controls Mitotic Checkpoint Disa
2026-05-04
This study reveals that Polo-like kinase 1 (Plk1) directly regulates the disassembly of mitotic checkpoint complexes by phosphorylating p31comet, thereby modulating spindle assembly checkpoint inactivation. The findings clarify a critical regulatory step in chromosome segregation and provide new mechanistic insight relevant for mitotic progression and cell cycle research.
-
Allosteric PDK4 Inhibitors as Therapeutic Leads for Metaboli
2026-05-03
This article examines the discovery of a novel class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, with an emphasis on compound 8c, which demonstrates potent in vitro activity and efficacy in preclinical models of metabolic and allergic diseases. The findings highlight allosteric modulation of PDK4 as a promising approach for addressing metabolic dysregulation, with implications for future drug development.
-
Latrunculin A: Dissecting Actin–Myosin II Networks in Antivi
2026-05-02
Discover how Latrunculin A, a reversible inhibitor of actin assembly, enables precise cytoskeletal disaggregation and advances antiviral research. Uniquely, this article explores actin–myosin II targeting for virus–host studies, offering actionable guidance and protocol insights.
-
EPZ5676: DOT1L Inhibitor Strategies for Precision Epigenetic
2026-05-01
EPZ5676 is reshaping epigenetic workflows as a potent and selective DOT1L inhibitor, enabling precise H3K79 methylation inhibition across oncology and fibrotic disease models. This deep-dive unpacks applied use-cases, cutting-edge protocol tips, and troubleshooting insights, directly bridging recent immune-epigenetic breakthroughs to actionable experimental design.
-
Inositol Phosphates Regulate Sin3L/Rpd3L HDAC via SAP30 Zinc
2026-05-01
This study reveals that inositol phosphates up-regulate deacetylase activity in the Sin3L/Rpd3L HDAC complex through an interaction with the SAP30 subunit’s zinc finger motif. The findings highlight convergent evolution of regulatory mechanisms in chromatin-modifying complexes and clarify how both inducible and constitutive subunit interactions modulate HDAC1/2 activity.